LCT.AX
Living Cell Technologies Ltd
Price:  
0.01 
AUD
Volume:  
1,378,040.00
Australia | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LCT.AX EV/EBITDA

-143.5%
Upside

As of 2025-07-03, the EV/EBITDA ratio of Living Cell Technologies Ltd (LCT.AX) is -8.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LCT.AX's latest enterprise value is 17.15 mil AUD. LCT.AX's TTM EBITDA according to its financial statements is -2.09 mil AUD. Dividing these 2 quantities gives us the above LCT.AX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 3.5x - 5.3x 4.4x
Forward P/E multiples 6.7x - 9.4x 8.4x
Fair Price (0.01) - (0.00) (0.01)
Upside -146.6% - -132.3% -143.5%
0.01 AUD
Stock Price
(0.01) AUD
Fair Price

LCT.AX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA